Genotyping of the CCR5 chemokine receptor by isothermal NASBA amplification and differential probe hybridization

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 6, 1999, Pages 959-965

  Romano, Joseph W ^a   Tetali, Surya ^b   Lee, Eun Mi ^a   Shurtliff, Roxanne N ^a   Wang, Xue Ping ^b   Pahwa, Savita ^b   Kaplan, Mark H ^b   Ginocchio, Christine C ^b  

^a ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ALLELE; ARTICLE; ASSAY; DNA HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL;

EID: 0032707324     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.6.959-965.1999     Document Type: Article

References (24)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC-CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
2. Blackburn, G., H. Shah, J. Kenten, J. Leland, R. A. Ramin, J. Link, J. Peterman, M. J. Powell, A. Shah, D. B. Talley, S. K. Tyagi, E. Wilkins, T. G. Wu, and R. J. Massey. 1991. Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics. Clin. Chem. 37:1534-1539.
3. Boom, R., C. J. Sol, M. M. Salisman, C. L. Jansen, P. M. E. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
4. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid gaunidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
5. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES. MIP-1α. and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
6. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikments, J. J. Goedert, S. P. Buchbinder, E. Vittinghoff, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, L. Rinaldo, R. Detels, and S. J. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273:1856-1862.
7. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR5. Nature 381:667-673.
8. Eugen-Olsen, J., A. K. Iversen, P. Garred, U. Koppelhus, C. Pedersen, T. L. Benfield, A. M. Sorensen, T. Katzenstein, E. Dickmeiss, J. Gerstoft, P. Skinhoj, A. Svejgaard, J. O. Nielsen, and B. Hofmann. 1997. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 11:305-310.
9. Huang, Y., W. A. Paxton, S. M. Wolinsky, A. U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jun, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N. R. Landau, J. Phair, D. D. Ho, and R. A. Koup. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240-1243.
10. Kievits, T., B. van Gemen, D. van Strijp, R. Schukkink, M. Dircks, H. Adriaanse, L. Malek, R. Sooknanan, and P. Lens. 1991. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods 35:273-286.
11. Kostrikis, L. G., Y. Huang, J. P. Moore, S. Wolinsky, L. Zhang, Y. Guo, J. Phaie, A. U. Neumann, and D. D. Ho. 1998. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat. Med. 4:350-353.
12. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
13. Martin, M. P., M. Dean, M. W. Smith, C. Winkler, B. Gerrard, N. L. Micheal, B. Lee, R. W. Doms, J. Margolick, S. Buchbinder, J. J. Goedert, T. R. O'Brien, M. W. Hilgartner, D. Vlahov, S. J. O'Brien, and M. Carrington. 1998. Genetic alteration of AIDS progression by a promoter variant of CCR5. Science 282:1907-1911.
14. McDermott, D. H., P. A. Zimmerman, F. Guignard, C. A. Kleeberger, S. F. Leitman, and P. M. Murphy. 1998. CCR5 promoter polymorphism and HIV-1 disease progression: Multicenter AIDS Cohort Study (MACS). Lancet 352:866-870.
15. McNicholl, J. M., D. K. Smith, S. H. Qari, and T. Hodge. 1997. Host genes and HIV: the role of chemokine receptor gene CCR5 and its allele. Emerg. Infect. Dis. 3:261-271.
16. Premack, B. A., and T. J. Schall. 1996. Chemokine receptors: gateways to inflammation and infection. Nat. Med. 2:1174-1178.
17. Quillent, C., E. Oberlin, J. Braun, D. Rousset, G. Gonzalez-Canali, P. Metais, L. Montagnier, J. L. Virelizier, F. Arenzana-Seisdedos, and A. Beretta. 1998. HIV-1 resistance phenotype conferred by combination of two separate inherited mutations of the CCR5 gene. Lancet 351:14-18.
18. Romano, J. W., R. N. Shurtliff, M. G. Sarngadharan, and R. Pal. 1995. Detection of HIV-1 infection in vitro using NASBA: an isothermal RNA amplification technique. J. Virol. Methods 54:109-119.
19. Samson, M., O. Labbe, C. Mollereau, G. Vassart, and M. Parmentier. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35:3362-3367.
20. Samson, M., F. Libert, B. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumerouilie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofstede, G. Burtonboy, M. George, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R. W. Doms, G. Vassart, and M. Parmentier. 1996. Resistance to HIV-I infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
21. Smith, M. W., M. Dean, M. Carrington, C. Winkler, G. A. Huttley, D. A. Lomb, J. J. Goedert, T. R. O'Brien, L. P. Jacobson, R. Kaslow, S. Buchbinder, E. Vittinghoff, D. Vlahov, K. Hoots, M. W. Hilgartner, and S. J. O'Brien. 1997. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS). Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS). San Francisco City Cohort (SFCC). ALIVE Study. Science 277:959-965.
22. 21a. Tetali, S. Unpublished data.
23. Wilkinson, D. A., E. A. Operskalski, M. P. Busch, J. W. Mosley, and R. A. Koup. 1998. A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS defining illness. J. Infect. Dis. 178:1163-1166.
24. Zimmerman, P. A., A. Buckler-White, G. Alkhatib, T. Spalding, J. Kubofcik, C. Combadiere, D. Weissman, O. Cohen, A. Rubbert, G. Lam, M. Vaccarezza, P. E. Kennedy, V. Kumaraswami, J. V. Giorgi, R. Detels, J. Hunter, M. Chopek, E. A. Berger, A. S. Fauci, T. B. Nutman, and P. M. Murphy. 1997. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Mod. 3:23-36.